Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratinocyte intercellular junction components are a specialized group of proteins that form the structural and functional framework of the skin's epidermal barrier. These components are categorized into four main types: desmosomes, adherens junctions, tight junctions, and gap junctions. Desmosomes, which include proteins such as desmoglein 1 and 3, provide the mechanical strength necessary to withstand physical stress, while tight junctions, composed of claudins and occludin, regulate the movement of water and solutes across the epithelium. Dysfunction or autoimmune targeting of these proteins results in significant dermatological pathologies, most notably pemphigus, where autoantibodies against desmogleins cause loss of cell-cell adhesion (acantholysis). Therapeutic interventions typically aim to preserve these junctions by suppressing the immune system or by using targeted biologics to reduce the levels of pathogenic autoantibodies.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratinocyte intercellular junction components.